National Institute on Drug Abuse; Notice of Closed Meeting, 70428-70429 [2016-24519]
Download as PDF
<![CDATA[
70428
Federal Register / Vol. 81, No. 197 / Wednesday, October 12, 2016 / Notices
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
mstockstill on DSK3G9T082PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, BPN: Small Molecule Drug
Discovery and Development.
Date: November 4, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Hotel, 2033 M Street,
NW., Washington, DC 20036.
Contact Person: Joel Saydoff, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892–9529, 301–496–9223,
joel.saydoff@nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Stroke Clinical Trials.
Date: November 8, 2016.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Lorien Hotel and Spa, 1600 King
Street, Alexandria, VA 22314.
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS, Neuroscience Center,
6001 Executive Blvd., Suite 3204, MSC 9529,
Bethesda, MD 20892–9529, 301–496–6033,
rajarams@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis; Panel Conference Grants R13.
Date: November 2, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 1066, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Barbara J. Nelson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1080, Bethesda, MD
20892–4874, 301–435–0806, nelsonbj@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: October 5, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Preclinical Medications Discovery and Abuse
Liability Testing for NIDA (8932).
Date: November 29, 2016.
[FR Doc. 2016–24520 Filed 10–11–16; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:13 Oct 11, 2016
Jkt 241001
Dated: October 5, 2016.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24515 Filed 10–11–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: November 10, 2016
Time: 11:30 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Suite
3049, 5635 Fishers Lane, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Barbara J Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Ste. 4076, MSC 9306, Bethesda,
MD 20892–9306, 301–402–0838,
barbara.thomas@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: October 5, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24516 Filed 10–11–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
E:\FR\FM\12OCN1.SGM
12OCN1
Federal Register / Vol. 81, No. 197 / Wednesday, October 12, 2016 / Notices
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: October 5, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–24519 Filed 10–11–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
United States Coast Guard (USCG)
[USCG–2016–0821]
Cook Inlet Regional Citizen’s Advisory
Council (CIRCAC) Charter Renewal
Coast Guard, DHS.
Notice of Recertification.
AGENCY:
ACTION:
The purpose of this notice is
to inform the public that the Coast
Guard has recertified the Cook Inlet
Regional Citizen’s Advisory Council
(CIRCAC) as an alternative voluntary
advisory group for Cook Inlet, Alaska.
This certification allows the CIRCAC to
monitor the activities of terminal
facilities and crude oil tankers under the
Cook Inlet Program established by
statute.
DATES: This recertification is effective
for the period from September 1, 2016
through August 31, 2017.
FOR FURTHER INFORMATION CONTACT: LT
Patrick Grizzle, Seventeenth Coast
Guard District (dpi), by phone at (907)
463–2809, email Patrick.J.Grizzle@
uscg.mil or by mail at P.O. Box 25517,
Juneau, Alaska 99802.
SUPPLEMENTARY INFORMATION:
mstockstill on DSK3G9T082PROD with NOTICES
SUMMARY:
Background and Purpose
As part of the Oil Pollution Act of
1990, Congress passed the Oil Terminal
and Oil Tanker Environmental
Oversight and Monitoring Act of 1990
(the Act), 33 U.S.C. 2732, to foster a
long-term partnership among industry,
government, and local communities in
overseeing compliance with
environmental concerns in the
VerDate Sep<11>2014
20:13 Oct 11, 2016
Jkt 241001
operation of crude oil terminals and oil
tankers.
On October 18, 1991, the President
delegated his authority under 33 U.S.C
2732 (o) to the Secretary of
Transportation in Executive Order
12777, section 8(g) (see 56 FR 54757;
October 22, 1991) for purposes of
certifying advisory councils, or groups,
subject to the Act. On March 3, 1992,
the Secretary re-delegated that authority
to the Commandant of the USCG (see 57
FR 8582; March 11, 1992). The
Commandant re-delegated that authority
to the Chief, Office of Marine Safety,
Security and Environmental Protection
(G–M) on March 19, 1992 (letter #5402).
On July 7, 1993, the USCG published
a policy statement, 58 FR 36504, to
clarify the factors that shall be
considered in making the determination
as to whether advisory councils, or
groups, should be certified in
accordance with the Act.
The Assistant Commandant for
Marine Safety and Environmental
Protection (G–M), re-delegated
recertification authority for advisory
councils, or groups, to the Commander,
Seventeenth Coast Guard District on
February 26, 1999 (letter #16450).
On September 16, 2002, the USCG
published a policy statement, 67 FR
58440, that changed the recertification
procedures such that applicants are
required to provide the USCG with
comprehensive information every three
years (triennially). For each of the two
years between the triennial application
procedures, applicants submit a letter
requesting recertification that includes a
description of any substantive changes
to the information provided at the
previous triennial recertification.
Further, public comment is not solicited
prior to recertification during
streamlined years, only during the
triennial comprehensive review.
On September 1, 2015, the Coast
Guard recertified the Cook Inlet
Regional Citizen’s Advisory Council
through August 31, 2016. Under the Oil
Terminal and Oil Tanker Environmental
Oversight Act of 1990 (33 U.S.C. 2732),
the Coast Guard may certify, on an
annual basis, an alternative voluntary
advisory group for Cook Inlet, Alaska.
This advisory group monitors the
activities of terminal facilities and crude
oil tankers under the Cook Inlet Program
established by Congress, 33 U.S.C. 2732
(b).
Recertification
By letter dated August 19, 2016, the
Commander, Seventeenth Coast Guard
certified that the CIRCAC qualifies as an
alternative voluntary advisory group
under 33 U.S.C. 2732(o). This
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
70429
recertification terminates on August 31,
2017.
Dated: August 19, 2016.
M.F. Mcallister,
Rear Admiral, U.S. Coast Guard Commander,
Seventeenth Coast Guard District.
[FR Doc. 2016–24643 Filed 10–11–16; 8:45 am]
BILLING CODE 9110–04–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–4280–
DR]; [Docket ID FEMA–2016–0001]
Florida; Major Disaster and Related
Determinations
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
This is a notice of the
Presidential declaration of a major
disaster for the State of Florida (FEMA–
4280–DR), dated September 28, 2016,
and related determinations.
DATES: Effective Date: September 28,
2016.
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street SW.,
Washington, DC 20472, (202) 646–2833.
SUPPLEMENTARY INFORMATION: Notice is
hereby given that, in a letter dated
September 28, 2016, the President
issued a major disaster declaration
under the authority of the Robert T.
Stafford Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121 et seq.
(the ‘‘Stafford Act’’), as follows:
SUMMARY:
I have determined that the damage in
certain areas of the State of Florida resulting
from Hurricane Hermine during the period of
August 31 to September 11, 2016, is of
sufficient severity and magnitude to warrant
a major disaster declaration under the Robert
T. Stafford Disaster Relief and Emergency
Assistance Act, 42 U.S.C. 5121 et seq. (the
‘‘Stafford Act’’). Therefore, I declare that such
a major disaster exists in the State of Florida.
In order to provide Federal assistance, you
are hereby authorized to allocate from funds
available for these purposes such amounts as
you find necessary for Federal disaster
assistance and administrative expenses.
You are authorized to provide Individual
Assistance and Public Assistance in the
designated areas and Hazard Mitigation
throughout the State. Consistent with the
requirement that Federal assistance be
supplemental, any Federal funds provided
under the Stafford Act for Hazard Mitigation
and Other Needs Assistance will be limited
to 75 percent of the total eligible costs.
Federal funds provided under the Stafford
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 81, Number 197 (Wednesday, October 12, 2016)]
[Notices]
[Pages 70428-70429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-24519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Preclinical Medications Discovery and Abuse
Liability Testing for NIDA (8932).
Date: November 29, 2016.
[[Page 70429]]
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: Lyle Furr, Scientific Review Officer, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1439, lf33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: October 5, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-24519 Filed 10-11-16; 8:45 am]
BILLING CODE 4140-01-P
